Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3747
+0.0265 (7.61%)
At close: Jun 17, 2025, 4:00 PM
0.3659
-0.0088 (-2.35%)
After-hours: Jun 17, 2025, 6:32 PM EDT
Turnstone Biologics Market Cap
Turnstone Biologics has a market cap or net worth of $8.67 million as of June 17, 2025. Its market cap has decreased by -85.75% in one year.
Market Cap
8.67M
Enterprise Value
-12.53M
1-Year Change
-85.75%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since the IPO on July 21, 2023, Turnstone Biologics's market cap has decreased from $255.86M to $8.67M, a decrease of -96.61%. That is a compound annual growth rate of -83.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 8.06M | -29.89% |
| Dec 31, 2024 | 11.49M | -80.45% |
| Dec 29, 2023 | 58.77M | -77.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |